DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Ganesan A, Crum-Cianflone N, Higgins J et al.
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 levels: results of a double-blind randomized placebo controlled clinical trial.
J Infect Dis 2011;
203: 756-764
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.